What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?

Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II trial (NCT05007925), investigating the use of an older Shockwave Peripheral IVL system, and the first-in-human FORWARD CAD IDE study (NCT06662500), evaluating the Shockwave Javelin IVL catheter.

Interview Questions:
1. What new IVL technologies are available, and what is the key data supporting their use?
2. How might these findings change the treatment approach for patients with calcified tibial disease?
3. What are the next steps for technology and research in this area?

Recorded remotely from Auckland, 2025.

Editors: Yazmin Sadik, Jordan Rance
Videographers: David Ben-Harosh and Oliver Miles

Support: This is an independent interview produced by Radcliffe Vascular.